Avista said it received widespread support from its Fund IV investors and also welcomed Capital Constellation, with which the firm formed a strategic partnership last year.
A statement attributed to Avista co-CEOs and managing partners Thompson Dean and David Burgstahler said, “The strong closing of the fund is an endorsement of our investment strategy, underpinned by many years of dedicated healthcare experience, the strength of our investment team, strong alignment of interest with our investors and Avista’s ability to generate consistent returns.
“The rising global demand for healthcare products and services will continue to present a host of compelling investment opportunities where our sector expertise can drive value creation and generate strong outcomes for our investors.”
Avista Capital Partners Announces Strategic Investment from Capital Constellation
Capital Constellation acquired a strategic minority interest in Avista Capital Partners, a leading New York-based healthcare focused private equity firm
News provided by
Share this article
Share this article
NEW YORK, Jan. 12, 2021 /PRNewswire/ Avista Capital Partners ( Avista ), a leading New York-based private equity firm with over $6 billion invested in more than 35 healthcare businesses globally, today announced a strategic partnership with Capital Constellation ( Constellation ). Constellation, a group of premier global institutional investors who provide catalytic investment capital and expertise to growing investment management platforms, is managed by leading private equity and alternative investment manager Wafra Inc. ( Wafra ). Avista focuses on five healthcare sub-verticals: medical devices and technologies, pharmaceuticals, pharma outsourcing, healthcare IT and distribution, and con